Cargando…
Development and Validation of a Nomogram for the Prediction of Unfavorable Treatment Outcome Among Multi-Drug Resistant Tuberculosis Patients in North West Ethiopia: An Application of Prediction Modelling
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a global problem and a health security threat, which makes “Ending the global TB epidemic in 2035” unachievable. Globally, the unfavourable treatment outcome remains unacceptably high. Therefore, this study aimed to develop a risk prediction m...
Autores principales: | Anley, Denekew Tenaw, Akalu, Temesgen Yihunie, Merid, Mehari Woldemariam, Tsegaye, Tewodros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317379/ https://www.ncbi.nlm.nih.gov/pubmed/35903578 http://dx.doi.org/10.2147/IDR.S372351 |
Ejemplares similares
-
Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling
por: Anley, Denekew Tenaw, et al.
Publicado: (2022) -
A Score to Predict the Risk of Major Adverse Drug Reactions Among Multi-Drug Resistant Tuberculosis Patients in Southern Ethiopia, 2014–2019
por: Bogale, Lemlem, et al.
Publicado: (2022) -
Unfavorable Treatment Outcome and Its Predictors Among Patients with Multidrug-Resistance Tuberculosis in Southern Ethiopia in 2014 to 2019: A Multi-Center Retrospective Follow-Up Study
por: Bogale, Lemlem, et al.
Publicado: (2021) -
Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
por: Merid, Mehari Woldemariam, et al.
Publicado: (2019) -
Tuberculosis and its associated risk factors among HIV-positive pregnant women in northwest Ethiopia: A retrospective follow-up study
por: Geremew, Habtamu, et al.
Publicado: (2023)